BRIEF published on 08/05/2024 at 07:35, 3 months 16 days ago Sensorion to Participate in Stifel's Biotech Summer Summit Investment Gene Therapy Sensorion Hearing Loss Biotech Summit 2024
PRESS RELEASE published on 08/05/2024 at 07:30, 3 months 16 days ago Inside Information / Other news releases Sensorion to participate in Stifel's Biotech Summer Summit 2024 to discuss strategic developments and gene therapy programs for hearing loss disorders Gene Therapy Sensorion Hearing Loss Disorders Stifel Biotech Summer Summit
BRIEF published on 06/27/2024 at 07:35, 4 months 24 days ago Sensorion Announces Appointment of New Chief Financial Officer Chief Financial Officer Biotechnology Sensorion Hearing Loss Laurene Danon
PRESS RELEASE published on 06/27/2024 at 07:30, 4 months 24 days ago Inside Information / Other news releases Sensorion appoints Laurene Danon as Chief Financial Officer, bringing 15 years of experience in investment banking. The company focuses on developing therapies for hearing loss disorders Chief Financial Officer Investment Banking Sensorion Laurene Danon Hearing Loss Therapies
BRIEF published on 05/30/2024 at 07:35, 5 months 22 days ago Sensorion announces the results of its Combined General Meeting Biotechnology Resolutions General Assembly Sensorion Hearing Therapies
BRIEF published on 05/28/2024 at 07:35, 5 months 24 days ago Sensorion Announces Participation in June 2024 Investor Conferences Biotechnology Investor Conferences Healthcare Sensorion Hearing Loss
PRESS RELEASE published on 05/28/2024 at 07:30, 5 months 24 days ago Inside Information / Other news releases Sensorion announces its participation in upcoming investor conferences in June 2024 to present its novel therapies for hearing loss disorders. The company will attend conferences in New York, Miami, and Lyon Biotechnology Investor Conferences June 2024 Sensorion Hearing Loss Disorders
Published on 11/21/2024 at 13:30, 37 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 37 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 7 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 7 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 7 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 32 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 52 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 9 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 47 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 22 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 22 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
